The Current Ratio as of November 2024 (TTM) for Imunon, Inc. (IMNN) is 2.30

According to Imunon, Inc.’s latest financial reports and current stock price. The company's current Current Ratio is 2.30. This represents a change of 4.83% compared to the average of 2.20 of the last 4 quarters.

Imunon, Inc. (IMNN) Historical Current Ratio (quarterly & annually)

How has IMNN Current Ratio performed in the past?

The mean historical Current Ratio of Imunon, Inc. over the last ten years is 3.36. The current 2.30 Current Ratio has changed 6.75% with respect to the historical average. Over the past ten years (40 quarters), IMNN's Current Ratio was at its highest in in the June 2021 quarter at 11.21. The Current Ratio was at its lowest in in the September 2017 quarter at 0.46.

Imunon, Inc. (IMNN) Current Ratio by Quarter and Year

Discovering the peaks and valleys of Imunon, Inc. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Imunon, Inc. (IMNN) Average Current Ratio

How has IMNN Current Ratio performed in the past?

The current Current Ratio of Imunon, Inc. (IMNN) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Imunon, Inc. (IMNN) Current Ratio vs. Peers

How is IMNN’s Current Ratio compared to its peers?

Imunon, Inc.’s Current Ratio is greater than Exicure, Inc. (0.71), greater than Cyclacel Pharmaceuticals, Inc. (0.77), less than Histogen Inc. (4.05), less than DiaMedica Therapeutics Inc. (11.81), less than Neoleukin Therapeutics, Inc. (15.33), greater than Senti Biosciences, Inc. (1.92), greater than Hillstream BioPharma, Inc. (2.25), less than SAB Biotherapeutics, Inc. (3.69), less than Quoin Pharmaceuticals, Ltd. (3.02), less than SAB Biotherapeutics, Inc. (3.69), less than Cingulate Inc. (7.35K), less than Bellicum Pharmaceuticals, Inc. (3.04), less than Lisata Therapeutics, Inc. (8.03), less than Lixte Biotechnology Holdings, Inc. (5.13), greater than Kineta, Inc. (0.14), less than Theriva Biologics, Inc. (2.67), less than Lumos Pharma, Inc. (2.66), less than Diffusion Pharmaceuticals Inc. (10.96), greater than Avalo Therapeutics, Inc. (1.42), greater than Catalyst Biosciences, Inc. (0),

Build a custom stock screener for Imunon, Inc. (IMNN) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Imunon, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Imunon, Inc. (IMNN) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Imunon, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.